RDIF expects 50 mn doses a month of Sputnik V vaccine production in India

The Drug Controller General of India (DCGI) on Monday registered the vaccine under the emergency use authorisation procedure, based on results of clinical trials in Russia, as well as positive data of additional Phase III local clinical trials in India conducted in partnership with Dr Reddy's Laboratories.
Source: The Economic Times - Category: Consumer Health News Source Type: news